Does androgen deprivation therapy in men with prostate cancer increase cardiovascular morbidity?

首页> 外文期刊>Nature clinical practice:Urology >Does androgen deprivation therapy in men with prostate cancer increase cardiovascular morbidity?

【24h】

Does androgen deprivation therapy in men with prostate cancer increase cardiovascular morbidity?

机译：前列腺癌男性的雄激素剥夺疗法会增加心血管疾病的发病率吗？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Androgen deprivation therapy (ADT) is the mainstay of treatment for metastatic prostate cancer. Cardiovascular disease is the most common cause of death in patients with prostate cancer, but few data regarding the effect of ADT on cardiovascular morbidity are available.The objective of this study was to examine the effects of ADT on cardiovascular outcomes in men with prostate cancer.

机译：雄激素剥夺疗法（ADT）是转移性前列腺癌的主要治疗手段。心血管疾病是前列腺癌患者最常见的死亡原因，但尚无有关ADT对心血管疾病发病率影响的数据。本研究的目的是研究ADT对前列腺癌男性心血管结局的影响。

著录项

来源
《Nature clinical practice:Urology》 |2008年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
Cancer of Prostate; Cardiovascular; Deprivation; morbidity aspects; Therapeutic procedure;

机译：前列腺癌;心血管;剥夺;发病率;治疗程序;

相似文献

外文文献
中文文献
专利

1. Reply from Authors re: Ronald C. Chen. Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome? Eur Urol 2016;69:211-2 Outcomes for Favorable and Unfavorable Intermediate Risk Prostate Cancer Patients Receiving Radiation Therapy With or Without Short-term Androgen Deprivation Therapy [J] . Voog Justin C., Paulus Rebecca, Efstathiou Jason A. European urology . 2016,第2期

机译：作者的回复：Ronald C. Chen。关于是否在前列腺癌中使用雄激素剥夺疗法和放射疗法的决定：心血管疾病死亡率是最相关的结果吗？ Eur Urol 2016; 69：211-2接受或不接受短期雄激素剥夺疗法的放射治疗的中危险前列腺癌患者的有利和不利结果
2. Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer [J] . Kohutek Zachary A., Weg Emily S., Pei Xin, Urology . 2016,第Null期

机译：雄激素剥夺治疗对临床局部前列腺癌放射治疗后心血管发病的长期影响
3. Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer EDITORIAL COMMENT [J] . Nguyen Paul L. Urology . 2016,第Null期

机译：雄激素剥夺治疗对临床局部前列腺癌放射治疗后心血管发病率的长期影响
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy [D] . TAKEI, Akinori 2019

机译：雄激素剥夺治疗的持续时间和最低20 ng / dL的睾丸激素最低值可预测接受外照射的前列腺癌患者的睾丸激素恢复至超水平
6. Long-term Impact of Androgen-Deprivation Therapy on Cardiovascular Morbidity after Radiotherapy for Clinically Localized Prostate Cancer [O] . Zachary A. Kohutek, Emily Steinberger, Xin Pei, -1

机译：雄激素剥夺疗法对临床局部前列腺癌放疗后心血管疾病的长期影响
7. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer [O] . Christopher S. Saigal, John L. Gore, Tracey L. Krupski, 2015

机译：雄激素剥夺疗法增加了患有前列腺癌的男性的心血管疾病发病率

Does androgen deprivation therapy in men with prostate cancer increase cardiovascular morbidity?

摘要

著录项

相似文献

相关主题

期刊订阅